Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 1 | Allergy, Asthma & Clinical Immunology

Fig. 1

From: Hereditary angioedema with an acute attack resolved after bone marrow transplantation for acute myeloid leukemia: a case report

Fig. 1

Clinical course of a patient with hereditary angioedema and acute myeloid leukemia. At the age of 39 years, the patient had AML and received BMT from a bone marrow bank. Consequently, he fully recovered from AML and remained in remission. Before he underwent BMT, he experienced acute HAE attacks approximately every 3 months from his 20 s. After BMT, his plasma C1-INH function increased as follows: < 25%, 29%, 37%, and 45.6%, and this increase in C1-INH function was associated with the reduced frequency of acute attacks. AML, acute myeloid leukemia; BMT, bone marrow transplantation; C1-INH, C1-inhibitor; HAE, hereditary angioedema

Back to article page

Allergy, Asthma & Clinical Immunology

ISSN: 1710-1492

Contact us